Inventor
Christopher Blackburn
Inventor
Natick, MA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes10%
C07CAcyclic or carbocyclic compounds6%
A61JContainers specially adapted for medical or pharmaceutical purposes4%
G06FElectric digital data processing4%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data4%
H01RElectrically-conductive connections4%
A61BDiagnosis2%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers2%
PatentTitleYear
11,125,958Optical pluggable module for a communication system202111,081,821Direct mate cable assembly202110,124,940Systems, methods, and devices for dispensing one or more substances20189,870,450'Drug delivery regulator'20189,382,197'Substituted hydroxamic acids and uses thereof'20169,321,731'Substituted hydroxamic acids and uses thereof'20169,249,142'Substituted hydroxamic acids and uses thereof'20169,227,951'Substituted hydroxamic acids and uses thereof'20169,096,518'Substituted hydroxamic acids and uses thereof'20158,952,163'Substituted hydroxamic acids and uses thereof'20158,946,223'Substituted hydroxamic acids and uses thereof'20158,624,040'Substituted hydroxamic acids and uses thereof'20148,546,588'Substituted hydroxamic acids and uses thereof'20138,471,026'Substituted hydroxamic acids and uses thereof'20137,935,694'Lactam compounds useful as protein kinase inhibitors'20117,790,719'Modulators of melanocortin receptor'20107,459,448'Lactam compounds useful as protein kinase inhibitors'20087,365,070'Modulators of melanocortin receptor'20086,921,821'Antagonists of melanin concentrating hormone receptor'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2016Based in Natick, MA, US· patent location history
2008–2016Patents assigned to MILLENNIUM PHARM INC (12)· patent assignee history
2008–2010Patents assigned to ORE PHARMACEUTICALS INC (2)· patent assignee history
2013–2015Patents assigned to BLACKBURN CHRISTOPHER (5)· patent assignee history
2013–2015Patents assigned to GIGSTAD KENNETH M (5)· patent assignee history
2013–2015Patents assigned to XU HE (5)· patent assignee history
2018Based in Las Vegas, NV, US· patent location history
2021Based in Bothell, WA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MILLENNIUM PHARM INC | 12 | 2008–2016 |
| BLACKBURN CHRISTOPHERself | 5 | 2013–2015 |
| GIGSTAD KENNETH M | 5 | 2013–2015 |
| XU HE | 5 | 2013–2015 |
| ORE PHARMACEUTICALS INC | 2 | 2008–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Natick, Massachusetts, US | 15 | 2005–2016 |
| Bothell, Washington, US | 2 | 2021 |
| Las Vegas, NV, US | 2 | 2018 |